ZLAB- A journey of a thousand miles from the first stepsZLAB- A journey of a thousand miles from the first steps -Early entry on inversed Head n Shoulder pattern. -Key level and demand zone support. -Vol confirm. . More plans on FB group US STOCKS- WALL STREET DREAMby phanvinhhai0
$ZLAB: Interesting weekly base$ZLAB is an interesting biotech stock, with a couple potentially explosive catalysts during 2023. There's a nice weekly signal here indicating the stock is accumulated and ready to move up strongly over time. Remember to size these names considering the extreme volatility that can occur after drug trial data comes out, or if they receive an FDA approval, etc. Best of luck! Cheers, Ivan Labrie.Longby IvanLabrie222
Stock Idea: $ZLAB (27 Jan 2023)$ZLAB - Hot sector: China and biotechs - Building tight flag above 10 DMA - Low cheat below $50 pivot of larger baseLongby TheHermitTrader_110
ZLAB .possible end of trend downI consider that at 22.62 the down trend has all the chances to have ended and it is possible to go up in a new upward trendLongby succes0
Long $ZLAB for a while$ZLAB is a Chinese biotech company specializing in the treatment of cancer, among other things. In December an insider bought 4,000 shares. Also, hedge funds have been increasing their exposure to $ZLAB for the last 4 quarters. The stop is 7% below at the red line. There are 2 upper trend lines (yellow). My feeling is that $ZLAB will be unsuccessful at getting through both of these levels of resistance. However, they are about 31% above. This is a more than 4:1 reward/risk ratio. Also note that $ZLAB has earnings on Mar 1 after hours. 87M float on this oneLongby itssean3100
Zai Lab and Entasis Therapeutics Announce Positive Topline ResulZLAB,ETTX: Zai Lab Limited 2021-10-19 09:00:00 Zai Lab and Entasis Therapeutics Announce Positive Topline Results for Sulbactam-Durlobactam (SUL-DUR) from Phase 3 ATTACK TrialLongby RocketTickers0
Zai Lab Soon To Release Clinical Trial DataZai Lab has partnered with Five Prime Therapuetics in the making and testing of the cancer treatment drug FPA144 + chemo (FIGHT). The stock is projected to rise 20+% on Friday, January 15, when the data is released. The data will be released 10:00-11:15 EST. Like and Follow if you want to see more trades like this.by Investor43214
Zai Lab Partner MacroGenics Announces FDA Approval of MARGENZA™ ZLAB,MGNX: Zai Lab Limited 2020-12-16 20:15:08 Zai Lab Partner MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast CancerLongby RocketTickers0
Zai Lab Announces Positive Topline Results from the NORA Phase 3ZLAB: Zai Lab Limited 2020-05-28 07:37:40 Zai Lab Announces Positive Topline Results from the NORA Phase 3 Study of ZEJULA® as Maintenance Therapy for Chinese Patients with Platinum-sensitive, Recurrent Ovarian CancerLongby RocketTickers5
ZAI LAB $ZLABAfter hit the pivot resistance, $ZLAB is pulling back to the support zone. It will most likely form a handle. If it breaks out $63.95, the pattern will be confirmed.Longby TheBullseye10
Zai Lab $ZLAB exactly the kind of coiled set-up to look forZLAB an intriguing name, saw strong accumulation opening month of year and has restedLongby OPTIONSHAWK1
Retraced All Gains, Like This For Short Term SwingSecondary offering of 7.5 million shares at $20 per share. Sell $20.00ish I think the overreaction is due to investors starting to tighten up the belt due to market conditions. Again, this is just a quick swing off this full retracement. This just seems a bit overly reactionary to me. Stop 10% Longby alipipefitterUpdated 2